BIOG vs. SAIN, SLPE, TMPL, MUT, NBPE, OCI, IEM, MRCH, AGT.LN, and TFIF
Should you be buying The Biotech Growth Trust stock or one of its competitors? The main competitors of The Biotech Growth Trust include Scottish American Investment (SAIN), Standard Life Private Equity Trust (SLPE), Temple Bar (TMPL), Murray Income Trust (MUT), NB Private Equity Partners (NBPE), Oakley Capital Investments (OCI), Impax Environmental Markets (IEM), The Merchants Trust (MRCH), AVI Global Trust (AGT.LN), and TwentyFour Income (TFIF). These companies are all part of the "asset management" industry.
The Biotech Growth Trust vs.
Scottish American Investment (LON:SAIN) and The Biotech Growth Trust (LON:BIOG) are both small-cap financial services companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, community ranking, valuation, institutional ownership and profitability.
Scottish American Investment has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, The Biotech Growth Trust has a beta of 0.5, suggesting that its stock price is 50% less volatile than the S&P 500.
16.3% of Scottish American Investment shares are held by institutional investors. Comparatively, 28.6% of The Biotech Growth Trust shares are held by institutional investors. 1.1% of Scottish American Investment shares are held by insiders. Comparatively, 0.7% of The Biotech Growth Trust shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, The Biotech Growth Trust had 1 more articles in the media than Scottish American Investment. MarketBeat recorded 1 mentions for The Biotech Growth Trust and 0 mentions for Scottish American Investment. The Biotech Growth Trust's average media sentiment score of 1.85 beat Scottish American Investment's score of 0.00 indicating that The Biotech Growth Trust is being referred to more favorably in the news media.
The Biotech Growth Trust received 78 more outperform votes than Scottish American Investment when rated by MarketBeat users. However, 80.00% of users gave Scottish American Investment an outperform vote while only 64.06% of users gave The Biotech Growth Trust an outperform vote.
Scottish American Investment has a net margin of 115.71% compared to The Biotech Growth Trust's net margin of 95.33%. The Biotech Growth Trust's return on equity of 26.96% beat Scottish American Investment's return on equity.
Scottish American Investment has higher earnings, but lower revenue than The Biotech Growth Trust. The Biotech Growth Trust is trading at a lower price-to-earnings ratio than Scottish American Investment, indicating that it is currently the more affordable of the two stocks.
Summary
The Biotech Growth Trust beats Scottish American Investment on 8 of the 15 factors compared between the two stocks.
Get The Biotech Growth Trust News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Biotech Growth Trust Competitors List
Related Companies and Tools
This page (LON:BIOG) was last updated on 5/2/2025 by MarketBeat.com Staff
Buy BIOG Stock Free BIOG Stock Alerts